Soy study suggests reduced prostate cancer risk

by Eric Schroeder
Share This:

ST. PAUL, MINN. — A new study appearing in the Oct. 1 issue of The Journal of Nutrition suggests consumption of soy protein may play a key role in reducing the risk of prostate cancer in men. As part of the study, 58 men supplemented their diets with 1 of 3 protein isolates — isoflavone-rich soy protein isolate (SPI+), alcohol-washed soy protein isolate (SPI-), or milk protein isolate (MPI) — each with 40 grams of protein per day. Both soy groups had higher urinary estradiol excretion than the MPI group at three and six months. "After taking biopsies of prostate tissue, androgen receptors were reduced in the prostate, which is consistent with a reduced risk of prostate cancer," said Dr. Mindy Kurzer, lead author of the study and a professor in the Department of Food Science and Nutrition at the University of Minnesota. "In addition, significantly fewer of the men who consumed soy protein progressed to cancer by the end of the six-month study. We are encouraged by the results, but more studies must be performed."

Comment on this Article
We welcome your thoughtful comments. Please comply with our Community rules.



The views expressed in the comments section of Food Business News do not reflect those of Food Business News or its parent company, Sosland Publishing Co., Kansas City, Mo. Concern regarding a specific comment may be registered with the Editor by clicking the Report Abuse link.